P. Bougnoux

Prognostic significance of breast relapse after conservative treatment in node-negative early breast cancer.

G. Calais, B. Chauvet, J. Lansac, 1990, International journal of radiation oncology, biology, physics.

Neoadjuvant docetaxel for operable breast cancer induces a high pathological response and breast-conservation rate

F. Penault-Llorca, F. Kwiatkowski, P. Chollet, 2003, British Journal of Cancer.

Sequential or alternating administration of docetaxel (Taxotere®) combined with FEC in metastatic breast cancer: a randomised phase II trial

M Namer, M. Namer, M. Tubiana-Hulin, 2002, British Journal of Cancer.